VEGFA and hepatocellular carcinoma: A major cause of immune resistance and poor efficacy in HCC patients is immune evasion, which is often due to insufficient infiltration of immune cells [136].However, the combination of anti-PD-L1 and anti-VEGF-A therapy has proved effective in HCC treatment (as mentioned above).